Generics 39

Originals

Biosimilars

Medical devices

Nutraceuticals

Filters

Drospirenone manufacturers

39 products found

Filters

39 products found

drospirenone + drospirenone

Tablets, film coated 3 mg + 30 mcg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
MAs available in
Lithuania , Malta
Manufacturer #21467

This global pharmaceutical company is dedicated to improving patients' lives through high-quality, differentiated products and services. They leverage a collaborative network to achieve success in key regions like the EU and North America. Their focus areas include women's health, infectious diseases, and potentially other therapeutic areas based on their recent approvals and launches. They produce prescription medications (including injectables) and tablets, demonstrating expertise in various dosage forms. The company holds GMP certifications and boasts successful product patents, solidifying its commitment to quality and innovation.

Manufacturer usually replies in 0 days

drospirenone + ethinylestradiol

Tablets, film coated 3 mg / 0.03 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
Switzerland
GMP approvals
EU GMP
Manufacturer #354
This global company specializes in developing and distributing generic medicines and consumer healthcare products. Established in 1990, it boasts decades of experience in research and development, focusing on complex "hard-to-make" medications with high added value. Their expertise spans critical care (oncology, cardiology, neurology, infectious diseases, antifungals), women's health (oral contraceptives, endometriosis treatments), and consumer healthcare (natural formulations for fertility, immunity, and metabolic disorders). They prioritize patient well-being and equitable access to innovative medicines, manufacturing products in Europe with an eco-responsible approach. Their commitment to excellence is evident through rigorous quality standards and a culture of continuous improvement.

Manufacturer usually replies in 1 days

drospirenone + ethinylestradiol

Tablets, film coated 3 mg + 0.02 mg

Dossier type
EU CTD
Dossier status
Ready to file
Country of origin
European Union
GMP approvals
EU GMP
Comments
Ref: Flexyess®, Yasminelle®, Yaz®
Manufacturer #252
This company is a leading player in the pharmaceutical industry, boasting decades of experience in research, development, and manufacturing. They specialize in the production of a wide range of pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) for both human and veterinary use. Their product portfolio spans multiple therapeutic areas, including but not limited to, oncology, cardiology, and other essential therapeutic categories. They offer a comprehensive range of services, including contract manufacturing (CMO) and the production of over-the-counter (OTC) products. The company holds EU and US GMP approvals for its production lines, ensuring adherence to rigorous quality standards. Their production lines encompass various dosage forms, including solids, liquids, and injectables. Their global presence extends across Europe and North America, with a network of 10 manufacturing facilities. They have a strong commitment to research and development, with dedicated teams focusing on innovative solutions and advancements in the pharmaceutical field.

Manufacturer usually replies in 1 days

Want to see all 39 products?

Subscribe today to benefit from:

  • Streamlined product sourcing - the leading CTD dossiers database focused on finished dosage formulations

  • Direct negotiations - connect and negotiate directly with manufacturers without any brokerage fee

  • Increased profitability - secure the best commercial terms for your business by comparing offers from several manufacturers

Request Subscription

Drospirenone:

Drospirenone, also known under the brand name Slynd, or in combination with oestrogen where it is commonly sold under the name Yasmin, is a progestin medication which is used in birth control pills. These pharmaceutical products are prescribed to prevent pregnancy and are also used in menopausal hormone therapy, along with the treatment of a few other indications.
Drospirenone is known as a fourth-generation progestin, with the original patent being granted to the drugs manufacturing company Schering AG in 1976 and subsequently emerged onto the medical marketplace in 2000. With drospirenone manufacturers and drospirenone suppliers being granted additional patents including WIPO and US in 1998 and 2000, respectively. More recently, the medication was approved for use in menopausal hormone therapy in combination with estradiol in 2005 and was introduced for use as a progestogen-only birth control pill in 2019.
Currently, due to the expiration of patents and its wide regulatory approval, drospirenone has become cost-effective for distributors to list for sale and wholesale on the global marketplace. As such, drospirenone, especially in combination with ethinylestradiol, has become widely available for order at a variety of price points and quantities.

Method of action of drospirenone:

Drospirenone functions through its antiandrogen effects, improving acne and hirsutism, while also inhibiting the maturation of follicles and ovulation, preventing pregnancy. It is an analogue of the diuretic spironolactone, which involves anti-mineralocorticoid activity, inhibiting aldosterone receptors, which increases sodium and water excretion. In essence, drospirenone suppresses the release of both the follicle-stimulating hormone and luteinizing hormone, preventing ovulation, while also inducing other changes which may aid in pregnancy prevention. Such as alterations in cervical mucus consistency, hindering sperm movement, and lowering the chance of embryo implantation.

Form and dosage of drospirenone:

As with other drugs, the final form and packaging are dependent on the manufacturers and suppliers, as well as the specific distributor and order. However, drospirenone is predominantly listed for sale as a combination medication along with ethinylestradiol. It comes in forms including tablets and film-coated tablets which are taken orally, with or without food. Typically for use in pregnancy prevention and menstruation regulation, it is recommended that the medication be taken once daily during the 21-day cycle, followed by 7 days abstinence. For the use in the treatment of other indications, drospirenone regimes tend to be bespoke to the needs of the specific patient, as such, the prescribing medical official’s and manufacturers’ instructions should be adhered to.

Drospirenone on Pipelinepharma:

Currently, we have found 13 trusted drospirenone manufacturers and drospirenone suppliers from our online global list of B2B sellers. These distributors have drospirenone available for order online and are located in countries including India, Brazil, the European Union, and Argentina. Each of the manufacturing and B2B wholesale companies on our online pharmaceutical products list has been verified by the Pipelinepharma team according to strict quality control. This ensures a hassle-free sourcing experience and reduces buyer mileage.

Price of drospirenone and how to buy:

Although the cost of drospirenone is highly dependent on numerous factors, a cursory search online reveals a typical B2B wholesale cost at approximately USD 18.92 for 63 tablets of drospirenone at 3 mg and ethinylestradiol at 30 micrograms. These values are for the NHS in the UK, as such are only intended for reference. Finding drospirenone manufacturers and drospirenone suppliers on the Pipelinepharma company marketplace is easy, simply search for the desired pharmaceutical products, select the listing of choice, and then press either the ‘Accept’, ‘Negotiate’, or ‘Get offer’ button on the online interface to begin a transaction.

Interested in Subscription?

Please fill out form and send us your specific requirements, and we will get back to you as soon as possible